Cell of origin and cancer stem cells in tumor suppressor mouse models of glioblastoma

Sheila R. Alcantara Llaguno, Xuanhua Xie, Luis F. Parada

Research output: Contribution to journalArticle

Abstract

The cellular origins and the mechanisms of progression, maintenance of tumorigenicity, and therapeutic resistance are central questions in the glioblastoma multiforme (GBM) field. Using tumor suppressor mouse models, our group recently reported two independent populations of adult GBM-initiating central nervous system progenitors. We found different functional and molecular subtypes depending on the tumor-initiating cell lineage, indicating that the cell of origin is a driver of GBMsubtype diversity. Using an in vivo model, we also showed that GBM cancer stem cells (CSCs) or glioma stem cells (GSCs) contribute to resistance to chemotherapeutic agents and that genetic ablation of GSCs leads to a delay in tumor progression. These studies are consistent with the cell of origin and CSCs as critical regulators of the pathogenesis of GBM.

Original languageEnglish (US)
Pages (from-to)31-36
Number of pages6
JournalCold Spring Harbor Symposia on Quantitative Biology
Volume81
Issue number1
DOIs
StatePublished - 2016

Fingerprint

Neoplastic Stem Cells
Glioblastoma
Stem cells
Tumors
Glioma
Neoplasms
Stem Cells
Neurology
Cell Lineage
Ablation
Central Nervous System
Maintenance
Population
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Cell of origin and cancer stem cells in tumor suppressor mouse models of glioblastoma. / Alcantara Llaguno, Sheila R.; Xie, Xuanhua; Parada, Luis F.

In: Cold Spring Harbor Symposia on Quantitative Biology, Vol. 81, No. 1, 2016, p. 31-36.

Research output: Contribution to journalArticle

Alcantara Llaguno, Sheila R. ; Xie, Xuanhua ; Parada, Luis F. / Cell of origin and cancer stem cells in tumor suppressor mouse models of glioblastoma. In: Cold Spring Harbor Symposia on Quantitative Biology. 2016 ; Vol. 81, No. 1. pp. 31-36.
@article{3cf890f30fed472fb2770df7f7eb4c22,
title = "Cell of origin and cancer stem cells in tumor suppressor mouse models of glioblastoma",
abstract = "The cellular origins and the mechanisms of progression, maintenance of tumorigenicity, and therapeutic resistance are central questions in the glioblastoma multiforme (GBM) field. Using tumor suppressor mouse models, our group recently reported two independent populations of adult GBM-initiating central nervous system progenitors. We found different functional and molecular subtypes depending on the tumor-initiating cell lineage, indicating that the cell of origin is a driver of GBMsubtype diversity. Using an in vivo model, we also showed that GBM cancer stem cells (CSCs) or glioma stem cells (GSCs) contribute to resistance to chemotherapeutic agents and that genetic ablation of GSCs leads to a delay in tumor progression. These studies are consistent with the cell of origin and CSCs as critical regulators of the pathogenesis of GBM.",
author = "{Alcantara Llaguno}, {Sheila R.} and Xuanhua Xie and Parada, {Luis F.}",
year = "2016",
doi = "10.1101/sqb.2016.81.030973",
language = "English (US)",
volume = "81",
pages = "31--36",
journal = "Cold Spring Harbor Symposia on Quantitative Biology",
issn = "0091-7451",
publisher = "Cold Spring Harbor Laboratory Press",
number = "1",

}

TY - JOUR

T1 - Cell of origin and cancer stem cells in tumor suppressor mouse models of glioblastoma

AU - Alcantara Llaguno, Sheila R.

AU - Xie, Xuanhua

AU - Parada, Luis F.

PY - 2016

Y1 - 2016

N2 - The cellular origins and the mechanisms of progression, maintenance of tumorigenicity, and therapeutic resistance are central questions in the glioblastoma multiforme (GBM) field. Using tumor suppressor mouse models, our group recently reported two independent populations of adult GBM-initiating central nervous system progenitors. We found different functional and molecular subtypes depending on the tumor-initiating cell lineage, indicating that the cell of origin is a driver of GBMsubtype diversity. Using an in vivo model, we also showed that GBM cancer stem cells (CSCs) or glioma stem cells (GSCs) contribute to resistance to chemotherapeutic agents and that genetic ablation of GSCs leads to a delay in tumor progression. These studies are consistent with the cell of origin and CSCs as critical regulators of the pathogenesis of GBM.

AB - The cellular origins and the mechanisms of progression, maintenance of tumorigenicity, and therapeutic resistance are central questions in the glioblastoma multiforme (GBM) field. Using tumor suppressor mouse models, our group recently reported two independent populations of adult GBM-initiating central nervous system progenitors. We found different functional and molecular subtypes depending on the tumor-initiating cell lineage, indicating that the cell of origin is a driver of GBMsubtype diversity. Using an in vivo model, we also showed that GBM cancer stem cells (CSCs) or glioma stem cells (GSCs) contribute to resistance to chemotherapeutic agents and that genetic ablation of GSCs leads to a delay in tumor progression. These studies are consistent with the cell of origin and CSCs as critical regulators of the pathogenesis of GBM.

UR - http://www.scopus.com/inward/record.url?scp=85021007355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021007355&partnerID=8YFLogxK

U2 - 10.1101/sqb.2016.81.030973

DO - 10.1101/sqb.2016.81.030973

M3 - Article

VL - 81

SP - 31

EP - 36

JO - Cold Spring Harbor Symposia on Quantitative Biology

JF - Cold Spring Harbor Symposia on Quantitative Biology

SN - 0091-7451

IS - 1

ER -